The Migraine Prevention Stack: Magnesium, Riboflavin, CoQ10, and Feverfew

Migraine prophylaxis is one of the few areas of supplement research with a real clinical guideline behind it. The 2012 American Academy of Neurology evidence-based update on migraine prevention assigned Level B (probably effective) recommendations to three nutraceuticals — magnesium, riboflavin (vitamin B2), and butterbur — and a Level C to feverfew and coenzyme Q10. Butterbur was subsequently dropped from most prescribing guidance after pyrrolizidine alkaloid hepatotoxicity concerns, so the practical four-component stack is magnesium, riboflavin, CoQ10, and feverfew. Each acts on a different aspect of migraine pathophysiology.

Layer 1: Magnesium, 400–600 mg Elemental Daily

Multiple double-blind RCTs in episodic migraine have shown that magnesium at 400–600 mg of elemental magnesium daily reduces monthly migraine frequency by roughly 40% versus placebo, with the largest effects in patients with menstrual migraine and migraine with aura. A 2018 meta-analysis of 21 trials confirmed a clinically meaningful prophylactic effect. Magnesium oxide is the form used in the original Peikert and Mauskop trials despite its poor absorption, so it remains the default; magnesium glycinate or threonate are reasonable alternatives if oxide causes diarrhea. Take in divided doses (200–300 mg twice daily) with food. Check renal function before starting and reduce dose if eGFR is below 30. See the riboflavin protocol for the second layer.

Layer 2: Riboflavin (Vitamin B2), 400 mg Daily

Riboflavin at 400 mg daily — a dose roughly 300 times the RDA — was first shown effective in Schoenen's 1998 placebo-controlled trial that became the basis for the AAN's Level B recommendation. Pooled analysis of subsequent RCTs found a roughly 50% reduction in monthly migraine days versus placebo at three-month follow-up. The mechanism is presumed to be improvement of mitochondrial flavin coenzyme function (FAD and FMN) in cells with marginal energy reserve, consistent with the broader view of migraine as a disorder of cortical energy metabolism. Side effects are minimal — bright yellow urine is universal and harmless. Pediatric trials have shown variable results; in adults the signal is consistent.

Layer 3: Coenzyme Q10, 100 mg Three Times Daily

The 2005 Sándor trial randomized 42 migraine patients to CoQ10 300 mg daily or placebo for three months and found a halving of attack frequency. A 2019 meta-analysis of 6 RCTs concluded that CoQ10 significantly reduced migraine days per month and headache duration versus placebo, though effect sizes were heterogeneous. Like riboflavin, CoQ10 is a mitochondrial cofactor — the convergent mechanism with B2 is one of the reasons this combination is recommended by headache neurologists. Use ubiquinone (the cheaper, more-studied form) unless you are over 50, on statins, or have absorption issues, in which case ubiquinol is reasonable. See our CoQ10 form comparison.

Layer 4: Feverfew, 100–125 mg Standardized Extract Daily

Feverfew (Tanacetum parthenium) has Level C AAN evidence — weaker than the first three layers but still positive in pooled analysis. Standardized to 0.2–0.4% parthenolide, doses of 100–125 mg daily reduced migraine frequency modestly in trials including a 2005 study of MIG-99 stable extract. Use the standardized extract, not raw leaf preparations, which have inconsistent parthenolide content. Side effects include mouth ulcers in 10% of users and a withdrawal syndrome ("post-feverfew syndrome") of rebound headaches if stopped abruptly — taper over 1–2 weeks. Avoid in pregnancy (uterotonic) and discontinue 2 weeks before surgery (mild antiplatelet effect).

What NOT to Add

Skip butterbur extracts despite their historical Level B rating — the unregulated supplement supply makes pyrrolizidine-alkaloid contamination a real risk and Germany withdrew approval in 2009. Melatonin has modest emerging evidence but is more useful for vestibular migraine and cyclical attacks than chronic prophylaxis. Avoid 5-HTP if you are on a triptan or any SSRI/SNRI — the serotonergic load is unwise. CBD oil for migraine has thin evidence; the topical/ingestible distinction is also poorly studied. See the migraine condition page for the wider picture including triptan vs CGRP-antagonist therapy.

How to Run the Stack

Add the layers one at a time, four weeks apart, so you can attribute effect or side effect to a specific component. Start with magnesium. Add riboflavin at week 4 if attacks haven't dropped meaningfully. Add CoQ10 at week 8. Add feverfew at week 12. Track migraine days on a calendar — a 50% reduction in monthly migraine days at 12 weeks is the standard benchmark for "responder." If you are below that threshold by week 16 of the full stack, this is the ceiling of supplement prophylaxis and you should be discussing CGRP-targeting therapy with a headache specialist. For acute attacks see our broader sleep-stack discussion — sleep disruption is the single largest amplifier of migraine frequency.

Bottom Line

This four-component stack has the strongest guideline-level support of any supplement protocol in any condition. It is cheap, safe, and produces a roughly 50% reduction in monthly migraine days in responders. It is not a substitute for triptan or gepant therapy for acute attacks, and it does not replace CGRP monoclonal antibodies in chronic migraine — but it sits underneath those interventions cleanly.